| Biological Sciences | Lifetime | 55 | US 33 | 99.99 |
| Cancer Research | Lifetime | 2 | US 2 | 99.99 |
| Molecular Biology | Lifetime | 100 | US 75 | 99.96 |
| Genetics | Lifetime | 166 | US 99 | 99.65 |
| Medical Genetics | Lifetime | 89 | US 51 | 99.35 |
| Oncology | Lifetime | 415 | US 237 | 99.29 |
| Immunology | Lifetime | 596 | US 304 | 98.22 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 871 | US 471 | 97.64 |
| Pathology and Forensic Medicine | Lifetime | 614 | US 282 | 97.24 |
| Hematology | Lifetime | 760 | US 376 | 93.07 |
| Cancer Research | 2021-2025 | 223 | US 77 | 87.70 |
| Cancer-related molecular mechanisms research | Lifetime | 1 | US 1 | 99.99 |
| MicroRNA in disease regulation | Lifetime | 1 | US 1 | 99.99 |
| Circular RNAs in diseases | Lifetime | 1 | US 1 | 100.00 |
| RNA modifications and cancer | Lifetime | 4 | US 2 | 99.96 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 18 | US 13 | 99.90 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 23 | US 11 | 99.78 |
| RNA Interference and Gene Delivery | Lifetime | 45 | US 25 | 99.77 |
| Extracellular vesicles in disease | Lifetime | 26 | US 10 | 99.54 |
| Cancer-related gene regulation | Lifetime | 48 | US 26 | 99.60 |
| Chromatin Remodeling and Cancer | Lifetime | 10 | US 4 | 99.56 |
| Epigenetics and DNA Methylation | Lifetime | 186 | US 113 | 99.40 |
| Genomic variations and chromosomal abnormalities | Lifetime | 60 | US 31 | 99.27 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 263 | US 164 | 99.45 |
| Lymphoma Diagnosis and Treatment | Lifetime | 179 | US 87 | 99.42 |
| RNA Research and Splicing | Lifetime | 201 | US 127 | 99.22 |
| Ubiquitin and proteasome pathways | Lifetime | 133 | US 72 | 99.26 |
| Galectins and Cancer Biology | Lifetime | 69 | US 30 | 98.82 |
| T-cell and Retrovirus Studies | Lifetime | 70 | US 33 | 98.90 |
| Cancer-related Molecular Pathways | Lifetime | 210 | US 124 | 99.15 |
| Peptidase Inhibition and Analysis | Lifetime | 328 | US 149 | 98.69 |
| Virus-based gene therapy research | Lifetime | 374 | US 249 | 98.78 |
| Acute Lymphoblastic Leukemia research | Lifetime | 313 | US 166 | 98.77 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 254 | US 130 | 98.73 |
| DNA Repair Mechanisms | Lifetime | 478 | US 270 | 97.89 |
| CAR-T cell therapy research | Lifetime | 759 | US 440 | 98.00 |
| Genomics and Chromatin Dynamics | Lifetime | 585 | US 337 | 97.58 |
| Cancer Cells and Metastasis | Lifetime | 939 | US 406 | 96.49 |
| Cancer Research and Treatments | Lifetime | 821 | US 432 | 96.30 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 928 | US 379 | 96.58 |
| Biochemical and Molecular Research | Lifetime | 739 | US 403 | 95.90 |
| Viral-associated cancers and disorders | Lifetime | 723 | US 330 | 96.55 |
| Polyomavirus and related diseases | Lifetime | 549 | US 258 | 95.83 |
| RNA regulation and disease | Lifetime | 768 | US 336 | 94.54 |
| Microtubule and mitosis dynamics | Lifetime | 945 | US 494 | 94.83 |
| Cell death mechanisms and regulation | Lifetime | 875 | US 351 | 94.57 |
| Nuclear Receptors and Signaling | Lifetime | 440 | US 207 | 94.28 |
| Cancer Mechanisms and Therapy | Lifetime | 956 | US 362 | 91.87 |
| Phagocytosis and Immune Regulation | Lifetime | 963 | US 378 | 88.77 |
| Protein Tyrosine Phosphatases | Lifetime | 863 | US 314 | 86.50 |
| MicroRNA in disease regulation | 2021-2025 | 372 | US 31 | 95.73 |
| RNA regulation and disease | 2021-2025 | 343 | US 98 | 82.06 |
